Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HER2-pulsed DC1 vaccine |
| Trade Name | |
| Synonyms | HER2-pulsed type-1 polarized autologous dendritic cell vaccine |
| Drug Descriptions |
HER2-pulsed DC1 vaccine is a cancer vaccine comprising patient-derived dendritic cells exposed to ERBB2 (HER2)-derived peptides, which potentially enhances anti-tumor immune response against ERBB2 (HER2)-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | HER2 (ERBB2) Vaccine 15 |
| CAS Registry Number | NA |
| NCIT ID | C114293 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HER2-pulsed DC1 vaccine | HER2-pulsed DC1 vaccine | 0 | 8 |
| HER2-pulsed DC1 vaccine + Paclitaxel + Pertuzumab + Trastuzumab | HER2-pulsed DC1 vaccine Paclitaxel Pertuzumab Trastuzumab | 0 | 1 |